Senores Pharmaceuticals Limited
NSE: SENORES | Information Technology
Market Fundamentals
Stock Intelligence & News
13 smallcap stocks see MF buying for 4 straight quarters; shares rally up to 103%
Mutual funds consistently raised stake in 97 smallcap stocks over four consecutive quarters. Among these, 13 smallcaps registered returns between 50% and 103% over the past year. Senores Pharmaceuticals led the rally, while counters like Astra Microwave, Data Patterns, and Ujjivan SFB saw steady institutional buying.
Read Full Analysis →Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited has informed the Exchange regarding Transcript of Earnings Conference Call held on Monday, July 27, 2026 for Q1FY27. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Senores Pharmaceuticals Ltd (544319)
Senores Pharmaceuticals Limited has informed the Exchange regarding Transcript of Earnings Conference Call held on Monday, July 27, 2026 for Q1FY27.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited has informed the Exchange regarding Newspaper Publication Extracts of Unaudited Financial Results of the Company for quarter ended June 30, 2026 |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation
Read Full Analysis →Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 27, 2026. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited has submitted to the Exchange outcome of Board Meeting dated July 27, 2026 |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Senores Pharmaceuticals Limited
SENORES PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 27-Jul-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2026 and Other business. |SUBJECT: Board Meeting Intimation
Read Full Analysis →Senores Pharmaceuticals Limited
Financial Results/Other business matters |Meeting Date: 27-Jul-2026
Read Full Analysis →Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited has informed the Exchange regarding Certificate pursuant to Regulation 74(5) of SEBI (DP)Regulations,2018 for quarter ended June 30, 2026 |SUBJECT: Certificate under SEBI (Depositories and Participants) Regulations, 2018
Read Full Analysis →Get instant alerts when SENORES breaks news
Join investors who track Senores Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for SENORES?
SENORES is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Senores Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding SENORES to your custom watchlist.